A pharmacogenetic study of aldehyde oxidase I in patients treated with XK469
Jacqueline Ramı́rez(University of Chicago), Mark J. Ratain(University of Chicago), Kouros Owzar(Duke University), Wanqing Liu(Purdue University West Lafayette), Federico Innocenti(AbbVie (United States)), Flora Mulkey(Sherwin Williams (United States)), Samir D. Undevia(University of Chicago), Eric R. Gamazon(Vanderbilt University), Tae Won Kim(Asan Medical Center), Jamie L. Myers(University of Chicago), Wendy Stock(University of Chicago), Dorothy Watson(University of North Carolina at Chapel Hill), Snezana Mirkov(Northwestern University)
Cited by 15
Related Papers
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
|Science|2015|5.7k
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
|The Lancet|2009|1.4k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k